GENERAL, O. Reg. 256/24
Section 50
Substances
Cite as GENERAL, O. Reg. 256/24, s. 50 · current to November 11, 2026 · consolidated from September 30, 2026 · read from e-Laws on November 16, 2026
The text
(1) For the purposes of paragraph 2 of subsection 4 (1) of the Act, a member referred to in subsection (2) of this section who meets all the requirements in subsection (4) is authorized to perform the following acts:
1. Administering a substance specified in Schedule 1 by injection.
2. Administering a substance specified in Schedule 2 by inhalation.
3. Administering a vaccine specified in Schedule 3 by injection. O. Reg. 256/24, s. 50 (1).
(2) A Part A pharmacist or an intern is authorized to perform an act provided for in subsection (1), subject to the terms, conditions and limitations imposed on their certificate of registration. O. Reg. 256/24, s. 50 (2).
(3) A Part A pharmacy technician or an intern technician who meets all the requirements in subsection (6) is authorized to perform an act provided for in paragraph 3 of subsection (1), subject to the terms, conditions and limitations imposed on their certificate of registration. O. Reg. 133/26, s. 1 (1).
(4) A member referred to in subsection (2) may only perform an act provided for in subsection (1) if the member complies with the following:
1. Before performing the act, the member must explain the purpose of the act to the patient or the patient’s authorized agent and receive an informed consent from the patient or the patient’s authorized agent.
2. The member shall ensure that the member only performs the act in an environment that is clean, safe, private and comfortable for the patient.
3. The member shall ensure that appropriate infection control procedures are in place.
4. The member must possess sufficient knowledge, skill and judgment respecting the substance to be administered, and sufficient understanding of the condition of the patient, to be able to administer the substance safely.
5. The member must consider whether administering a substance by injection or inhalation to the patient is appropriate, given the known risks and benefits to the patient and the safeguards and resources available to safely manage the outcome after administration and any other relevant circumstances.
6. The member must maintain a patient record that includes,
i. the name and address of the patient,
ii. the name and address of the member,
iii. the date the act was performed,
iv. the name, strength (where applicable) and quantity of the substance that the member administered to the patient,
v. the circumstances relating to the administration of the substance to the patient and any adverse reaction experienced by the patient, and
vi. confirmation that an informed consent was given by the patient or their authorized agent.
7. Where administering a substance specified in Schedule 1 by injection to a patient through an established central or peripheral venous access device, the member must only do so in collaboration with a member of the College of Nurses of Ontario who is a registered nurse in the extended class or a member of the College of Physicians and Surgeons of Ontario.
8. Where the act is performed for a purpose other than that of patient education or demonstration the member must, within a reasonable time after performing the act, notify the following persons that the member performed the act, and provide details respecting the act:
i. The prescriber, if any, of the substance that was administered.
ii. The patient’s primary care provider, where the member knows that the patient has such a care provider other than the prescriber.
9. Revoked: O. Reg. 133/26, s. 1 (2).
10. The member may only administer a vaccine to patients who are two years of age or older in the case of the influenza vaccine, six months of age and older in the case of the COVID-19 vaccines and five years of age or older in the case of every other vaccine. O. Reg. 256/24, s. 50 (4); O. Reg. 133/26, s. 1 (2)
(5) Where a limitation or a route of administration is indicated with respect to a substance listed in Schedule 1, a member shall only administer the substance in compliance with the limitation and in accordance with the route of administration specified. O. Reg. 256/24, s. 50 (5).
(6) A member referred to in subsection (3) may only perform the act of administering the vaccine by injection provided for in paragraph 3 of subsection (1) if the patient is two years of age or older in the case of the influenza vaccine, six months of age or older in the case of Coronavirus (COVID-19) vaccines and five years of age or older in the case of every other vaccine, and if the member,
(a) possesses sufficient knowledge, skill and judgment to be able to administer the vaccine safely;
(b) meets all the requirements in paragraphs 2, 3 and 6 of subsection (4);
(c) Revoked: O. Reg. 133/26, s. 1 (4).
(d) has confirmed that a member referred to in subsection (2), or another regulated health professional authorized to administer the vaccine by injection, has,
(i) received an informed consent from the patient or the patient’s authorized agent,
(ii) a sufficient understanding of the vaccine and condition of the patient for the vaccine to be administered safely, and
(iii) considered whether administering the vaccine by injection to the patient is appropriate, given the known risks and benefits to the patient and the safeguards and resources available to safely manage the outcome and any other relevant circumstances. O. Reg. 256/24, s. 50 (6); O. Reg. 133/26, s. 1 (3, 4).
Read the GENERAL on e-Laws ↗
Made under Pharmacy Act, 1991, S.O. 1991, c. 36.